SSA
LENZ

Schonfeld Strategic Advisors’s LENZ Therapeutics LENZ Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$359K Buy
+39,285
New +$552K ﹤0.01% 1507
2024
Q4 		– Sell
-107,300
Closed -$2.55M – 2466
2024
Q3 		$2.55M Buy
+107,300
New +$2.38M 0.02% 784
2022
Q4 		– Sell
-3,371
Closed -$75K – 3073
2022
Q3 		$75K Sell
3,371
-2,986
-47% -$71.2K ﹤0.01% 2598
2022
Q2 		$122K Buy
+6,357
New +$142K ﹤0.01% 2079

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Schonfeld Strategic Advisors's LENZ Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 39,285 shares worth $359K. The stake represents ﹤0.01% of the portfolio and ranks #1507 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in LENZ as recently as Q3 2024.

Schonfeld Strategic Advisors first reported a position in LENZ in Q2 2022 and has held it in 4 quarters since. The position peaked at $2.55M in Q3 2024. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Schonfeld Strategic Advisors held 39,285 shares of LENZ Therapeutics worth $359K as of Q1 2026.
  • LENZ Therapeutics was a new Schonfeld Strategic Advisors position in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1507 holding.
  • Schonfeld Strategic Advisors first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • Schonfeld Strategic Advisors's LENZ Therapeutics position peaked at $2.55M in Q3 2024.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.